On air · 1 of 3 networks
DKBmed
- dkbmed.com
- Education
- US
- 19 employees
DKBmed’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 33. Watch DKBmed with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 33 | Checked 30 Oct 2026 | See all 33 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 19 Oct 2026 | Collect them with the API → |
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 27 Oct 2026 | Collect them with the API → |
DKBmed has 33 live LinkedIn ads. Its Facebook page had no active ads on 19 Oct 2026, and we recorded no Google ads on 27 Oct 2026.
Latest ads
- LINKEDIN · IMAGERecorded 16 Sept 2026
Join our free CME/CE webinar as we dive into recent advancements in TNBC treatment, presenting practical case studies and critical information about personalized care.
- LINKEDIN · IMAGERecorded 16 Sept 2026
Join our free CME/CE webinar as we dive into recent advancements in TNBC treatment, presenting practical case studies and critical information about personalized care.
- LINKEDIN · IMAGERecorded 16 Sept 2026
Join our free CME/CE webinar as we dive into recent advancements in TNBC treatment, presenting practical case studies and critical information about personalized care.
- LINKEDIN · IMAGERecorded 16 Sept 2026
Triple-negative breast cancer presents unique challenges and an urgent need for effective, personalized therapies. Treating advanced TNBC requires a deep understanding of: -Biomarker testing -Immunotherapy -PARP inhibitors -Antibody-drug conjugates Join our free CME/CE webinar as we dive into recent advancements in TNBC treatment, presenting practical case studies and the latest data on managing treatment-related adverse events. Credits available: 1.0 AMA, ANCC, or AAPA
- LINKEDIN · IMAGERecorded 16 Sept 2026
Triple-negative breast cancer presents unique challenges and an urgent need for effective, personalized therapies. Treating advanced TNBC requires a deep understanding of: -Biomarker testing -Immunotherapy -PARP inhibitors -Antibody-drug conjugates Join our free CME/CE webinar as we dive into recent advancements in TNBC treatment, presenting practical case studies and the latest data on managing treatment-related adverse events. Credits available: 1.0 AMA, ANCC, or AAPA
- LINKEDIN · IMAGERecorded 16 Sept 2026
Triple-negative breast cancer presents unique challenges and an urgent need for effective, personalized therapies. Treating advanced TNBC requires a deep understanding of: -Biomarker testing -Immunotherapy -PARP inhibitors -Antibody-drug conjugates Join our free CME/CE webinar as we dive into recent advancements in TNBC treatment, presenting practical case studies and the latest data on managing treatment-related adverse events. Credits available: 1.0 AMA, ANCC, or AAPA
6 of 33 adsSign up to see every DKBmed ad, filter by format and date, and get alerts on new ones.
See all 33 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.